About Scorpion Therapeutics
Scorpion Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $297,375,413 raised in three offerings on Form D since May 2020. Its chief executive is Adam Friedman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 2024 | Jul 16, 2024 | $125,694,186of $150.0M target | 38 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Nov 20, 2020 | Dec 7, 2020 | $146,999,977target not set | 22 | $6.6M | EquityRule 506(b) | Form D ↗ |
| Apr 23, 2020 | May 19, 2020 | $24,681,250target not set | 11 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $297,375,413 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Scorpion Therapeutics's Form D filed Jul 16, 2024.
AF
ON
Oleg Nodelman
Director
OS
Otello Stampacchia
Director
AF
Adam Friedman
Chief Executive Officer and director
Also an executive officer and director at Antares Therapeutics.
SC
DS
Darrin Stuart
Executive officer
EJ
Erica Jackson
Executive officer
JF
AV
Amanda Valentino
Executive officer
JA
SS
Saurabh Saha
Director
AG
Arjun Goyal
Director
KF
MC
Mark Chao
Executive officer
BP
Earlier filings also listed Peter Campisi, Jr. (secretary, last listed Dec 2020) and Gary Glick (executive officer and director, last listed Dec 2020).